BioGenerator Ventures


BioGenerator Ventures creates, builds, and invests in early-stage companies addressing human health and agriculture. It provides staged, catalytic capital from an evergreen fund model and pairs investment with a company-building engine (BioGenerator Labs) that offers lab space, coaching, grant support, talent, and investor relations to de-risk and scale ventures.

BioGenerator Ventures


Services

Equity investments (staged and follow-on)

Provides catalytic, staged equity investments from an evergreen fund model and deploys follow-on capital for companies that meet technical and business milestones; syndicates deals with venture capital and other investors.

BioGenerator Labs — laboratory space and shared equipment

Flexible, low-cost collaborative wet lab and office space with state-of-the-art shared capital equipment; two facilities focused on human health (Cortex) and ag/food tech (39N).

Coaching and Executive-in-Residence (EIR) support

Coaching from Executives in Residence and BioGenerator staff providing mentorship, operational advice, board and leadership development, and hands-on support in company formation and growth.

Grant support and SBIR/STTR strategy

Grant-winning system offering training and one-on-one support to develop competitive non-dilutive federal grant applications (SBIR/STTR) and administers BioGenerator Proof of Concept grants.

Talent and VC fellowship program

Recruitment and placement of experienced Entrepreneurs/Executives in Residence and VC Fellows who support deal evaluation, company-building, and operational roles in portfolio companies.

Investor relations and capital attraction

Assistance in structuring financings and attracting follow-on investment from venture capital, private equity, and strategic investors globally.

View All Services

Portfolio

Published pivotal trial results; BioGenerator led an independent diligence process that catalyzed Series B.

#Diagnostics / Human health

Commercial partnership valuing the company at over $400M; later FDA approval of transdermal GFR system noted in site news.

#Medical devices / Diagnostics

Successful exit for investors following Bayer's control acquisition.

#Agriculture / Agtech

Acquired by Lightbeam Health Solutions.

#Healthcare / Digital health

Raised $172M to advance NK cell platform and programs.

#Therapeutics / Cell therapy

Went public in a $2 billion SPAC merger; BioGenerator led initial financing.

#Agtech / Food tech

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.